These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8952665)

  • 21. Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis.
    van Gestel A; Koopman R; Wijnands M; van de Putte L; van Riel P
    J Rheumatol; 1994 Oct; 21(10):1814-9. PubMed ID: 7837143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease.
    Salvador F; Sánchez-Montalvá A; Martínez-Gallo M; Sala-Cunill A; Viñas L; García-Prat M; Aparicio G; Sao Avilés A; Artaza MÁ; Ferrer B; Molina I
    Clin Infect Dis; 2015 Dec; 61(11):1688-94. PubMed ID: 26265500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lichenoid eruption produced by captopril.
    Reinhardt LA; Wilkin JK; Kirkendall WM
    Cutis; 1983 Jan; 31(1):98-9. PubMed ID: 6218969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of skin reactions when using ibuprofen-based medicines.
    Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
    Expert Opin Drug Saf; 2005 Sep; 4(5):837-48. PubMed ID: 16111447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitritoid reactions: case reports, review, and recommendations for management.
    Arthur AB; Klinkhoff A; Teufel A
    J Rheumatol; 2001 Oct; 28(10):2209-12. PubMed ID: 11669157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases.
    Pach J; Valido K; Belzer A; Leventhal JS
    Am J Clin Dermatol; 2024 Jul; 25(4):595-607. PubMed ID: 38767827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diffuse interstitial pneumopathy after the treatment with gold salts of a patient with rheumatoid polyarthritis].
    Strâmbu I; Stoicescu IP
    Pneumoftiziologia; 1997; 46(2):131-4. PubMed ID: 9567626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter
    J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drugs and drug combinations responsible for cutaneomucosal reactions].
    Dechy H
    Rev Stomatol Chir Maxillofac; 1976; 77(5):757-64. PubMed ID: 137515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cutaneous reactions to heparin: immunological and clinical aspects].
    Mathelier-Fusade P; Deschamps A; Abuaf N; Leynadier F
    Presse Med; 1995 Feb; 24(6):323-5. PubMed ID: 7899395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.
    Vila AT; Puig L; Fernández-Figueras MT; Laiz AM; Vidal D; Alomar A
    Br J Dermatol; 2005 Aug; 153(2):417-23. PubMed ID: 16086759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions.
    Klinkhoff AV; Teufel A
    J Rheumatol; 1995 Sep; 22(9):1657-9. PubMed ID: 8523340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
    van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR
    J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
    Lee HH; Song IH; Friedrich M; Gauliard A; Detert J; Röwert J; Audring H; Kary S; Burmester GR; Sterry W; Worm M
    Br J Dermatol; 2007 Mar; 156(3):486-91. PubMed ID: 17300238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of high resolution x-ray computed tomography in the diagnosis of hypersensitivity pneumopathy to gold salts. Apropos of a case].
    Vernhet H; Bousquet C; Cover S; Giron J; Gruson C; Senac JP
    Rev Mal Respir; 1995; 12(3):317-9. PubMed ID: 7638431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pityriasis rosea during etanercept therapy.
    Guarneri C; Polimeni G; Nunnari G
    Eur Rev Med Pharmacol Sci; 2009; 13(5):383-7. PubMed ID: 19961045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug-induced exanthemas].
    Chosidow O
    Rev Prat; 2000 Jun; 50(12):1310-3. PubMed ID: 10972071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the diagnosis of drug eruptions.
    de la Torre C; Suh Oh HJ
    Actas Dermosifiliogr; 2013 Nov; 104(9):782-8. PubMed ID: 23380423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Corneal chrysiasis. Gold salt deposits in the cornea in a patient with rheumatoid arthritis. An analysis with confocal microscopy].
    Santos-Bueso E; Ahmed-Wasfy M; Sáenz-Francés F; Gil-de-Bernabé J; Martínez-de-la-Casa JM; Benítez-del-Castillo JM; García-Feijoo J
    Arch Soc Esp Oftalmol; 2013 Jun; 88(6):237-9. PubMed ID: 23726309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.